Baltimore-Washington Financial Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$236K Sell
884
-10
-1% -$2.71K 0.01% 175
2025
Q4
$224K Buy
894
+9
+1% +$2.39K 0.01% 181
2025
Q3
$254K Buy
885
+72
+9% +$19.3K 0.01% 157
2025
Q2
$213K Sell
813
-101
-11% -$24.6K 0.01% 163
2025
Q1
$213K Sell
914
-20,742
-96% -$5.03M 0.01% 147
2024
Q4
$4.97M Sell
21,656
-1,021
-5% -$234K 0.26% 77
2024
Q3
$5.07M Sell
22,677
-719
-3% -$158K 0.27% 74
2024
Q2
$4.76M Sell
23,396
-1,030
-4% -$210K 0.28% 75
2024
Q1
$5.34M Sell
24,426
-39,268
-62% -$8.65M 0.33% 76
2023
Q4
$14.5M Buy
63,694
+2,629
+4% +$552K 1% 36
2023
Q3
$12.3M Sell
61,065
-9,720
-14% -$2.05M 0.99% 40
2023
Q2
$14.7M Sell
70,785
-15,509
-18% -$3.01M 1.17% 29
2023
Q1
$17M Sell
86,294
-964
-1% -$198K 1.5% 23
2022
Q4
$17.7M Sell
87,258
-186
-0.2% -$36.4K 1.73% 18
2022
Q3
$15.5M Buy
87,444
+909
+1% +$186K 1.3% 26
2022
Q2
$17.4M Buy
86,535
+6,141
+8% +$1.31M 1.86% 16
2022
Q1
$17.6M Sell
80,394
-5,237
-6% -$1.23M 1.72% 15
2021
Q4
$23.1M Buy
85,631
+2,483
+3% +$615K 1.87% 11
2021
Q3
$20.1M Buy
83,148
+1,994
+2% +$503K 1.77% 13
2021
Q2
$19.2M Buy
81,154
+661
+0.8% +$151K 1.79% 14
2021
Q1
$17.6M Buy
80,493
+1,127
+1% +$226K 1.8% 15
2020
Q4
$13.9M Buy
79,366
+2,825
+4% +$488K 1.51% 24
2020
Q3
$12.4M Buy
76,541
+1,656
+2% +$262K 1.6% 20
2020
Q2
$10.7M Buy
74,885
+670
+0.9% +$92.7K 1.47% 24
2020
Q1
$8.06M Buy
74,215
+582
+0.8% +$83.9K 1.45% 28
2019
Q4
$10.7M Buy
73,633
+2,865
+4% +$414K 1.57% 24
2019
Q3
$10.2M Buy
70,768
+13
+0% +$1.9K 1.68% 19
2019
Q2
$10.5M Buy
70,755
+582
+0.8% +$81.2K 1.77% 16
2019
Q1
$9.22M Buy
70,173
+2,635
+4% +$325K 1.61% 24
2018
Q4
$7.33M Buy
67,538
+681
+1% +$91.2K 1.52% 34
2018
Q3
$9.97M Buy
66,857
+3,883
+6% +$591K 1.8% 19
2018
Q2
$9.71M Buy
62,974
+4,340
+7% +$655K 1.93% 15
2018
Q1
$8.15M Buy
58,634
+1,667
+3% +$245K 1.78% 25
2017
Q4
$7.81M Buy
56,967
+710
+1% +$93.8K 1.64% 26
2017
Q3
$7.3M Buy
56,257
+2,754
+5% +$367K 1.66% 27
2017
Q2
$7.08M Buy
53,503
+7,374
+16% +$903K 1.7% 29
2017
Q1
$5.69M Buy
46,129
+1,507
+3% +$178K 1.45% 33
2016
Q4
$4.92M Buy
44,622
+483
+1% +$53.7K 1.35% 34
2016
Q3
$5.21M Sell
44,139
-902
-2% -$106K 1.48% 33
2016
Q2
$5.04M Buy
45,041
+198
+0.4% +$21.3K 1.5% 34
2016
Q1
$4.51M Buy
44,843
+4,292
+11% +$412K 1.37% 34
2015
Q4
$4.31M Buy
40,551
+1,217
+3% +$126K 1.35% 30
2015
Q3
$3.67M Buy
39,334
+29
+0.1% +$3K 1.16% 40
2015
Q2
$4.09M Buy
39,305
+815
+2% +$84.8K 1.22% 40
2015
Q1
$4.17M Sell
38,490
-874
-2% -$89.9K 1.21% 36
2014
Q4
$3.65M Buy
39,364
+2,122
+6% +$187K 1.08% 39
2014
Q3
$3.25M Buy
37,242
+1,042
+3% +$94.1K 1.04% 43
2014
Q2
$3.19M Buy
36,200
+279
+0.8% +$24.2K 0.99% 43
2014
Q1
$3.03M Buy
35,921
+4,501
+14% +$359K 1.03% 45
2013
Q4
$2.47M Buy
31,420
+271
+0.9% +$23.1K 0.83% 55
2013
Q3
$2.65M Buy
31,149
+629
+2% +$53K 1.05% 44
2013
Q2
$2.63M Buy
+30,520
New +$2.53M 1.14% 45

Other funds holding LH

Baltimore-Washington Financial Advisors's LH Position: Q1 2026 in Review

Baltimore-Washington Financial Advisors reduced its Labcorp (LH) stake by 1.1% in Q1 2026, selling an estimated $2.71K and leaving 884 shares worth $236K. The position accounts for 0.01% of the portfolio, ranked #175.

Baltimore-Washington Financial Advisors first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $23.1M in Q4 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Baltimore-Washington Financial Advisors held 884 shares of Labcorp worth $236K as of Q1 2026.
  • Baltimore-Washington Financial Advisors sold 10 Labcorp shares in Q1 2026, an estimated $2.71K.
  • Labcorp made up 0.01% of Baltimore-Washington Financial Advisors's portfolio in Q1 2026, its #175 holding.
  • Baltimore-Washington Financial Advisors first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Baltimore-Washington Financial Advisors's Labcorp position peaked at $23.1M in Q4 2021.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Baltimore-Washington Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.